Pancreatitis remains the most common complication of ERCP, occurring after 1% to 30% of
procedures, the frequency varying with thoroughness of follow-up, definition used, and …

Prophylaxis 1 ESGE recommends routine rectal administration of 100 mg of diclofenac or
indomethacin immediately before endoscopic retrograde cholangiopancreatography …

Acute pancreatitis is the most common and feared complication of endoscopic retrograde
cholangiopancreatography (ERCP). It is associated with substantial morbidity and …

2. Methods The European Society of Gastrointestinal Endoscopy (ESGE) commissioned this
guideline which was then endorsed by its Governing Board. The method used to formulate …

Background: ERCP is frequently complicated by pancreatitis. The aims of this study were to
assess the efficacy of somatostatin and gabexate for prevention of post-ERCP pancreatitis in …

Background: The identification of therapeutic agents that can prevent the pancreatic injury
after endoscopic retrograde cholangiopancreatography (ERCP) is of considerable …

Results: The morbidity rate for ES was 7.7%, being moderate to severe in 5%. Morbidity
included acute pancreatitis (3.5%), perforations (1.8%), sepsis (1.2%) and bleeding (1.2%) …

BACKGROUND: The prophylactic use of somatostatin or gabexate in patients undergoing
ERCP is still controversial. OBJECTIVE: Our purpose was to update the meta-analysis on …

Background: Pancreatic sphincter hypertension increases the risk of pancreatitis in patients
undergoing ERCP. Glyceryl trinitrate reduces sphincter of Oddi pressure. This study tested …

Background The efficacy of many pharmacological agents for preventing post‐ERCP
pancreatitis (PEP) has been evaluated in randomised controlled trials (RCT s), but it is …